Company

A wide range of therapeutic areas
Home > Company

Corporate Profile

Pharmazac is one of the fastest growing pharmaceutical firms in Greece and a top investor in Rx and Healthcare solutions. The company has been awarded several prizes for its performance and growing business units and has recently been characterised as one of the Greek Economy gems.

Pharmazac’s business units and activities cover the full spectrum of pharmaceutical services as it is operating in-house the development, regulatory, medical promotion, manufacturing and logistics of medicinal, herbal, food supplement and healthcare products.

The expanding assets today include installations of 22.000 sq.m. (9.100 under development), a portfolio of more than 100 licensed brands in Greece and a growing international pool of registrations as well as investments in top-tier projects. Moreover, a widening number of partnerships with large firms (GE, TAKEDA, SANDOZ etc) guarantees a swiftly growing reputation and exposure.

Pharmazac’s current developments and portfolio are expanding with a pipeline of more than 15 products to be completed by 2020.

Pharmazac in Numbers

  • Established in 1986

  • Products Portfolio (APIs): 86

  • Business Units: 8

  • 120 employees (20%  Business Development/R&D)

  • Locations: 5

  • Total Space: 23.908 sq.m.

  • 5 year growth: 42%

Executive Team

antonis-papageorgiou

Antonis studied Geology at the National & Kapodistrian University of Athens and holds a MBA from the Hellenic Management Association (EEDE). In 2009 he joins the pharmaceutical sector as a Key Account Manager at Proton Pharma and later promoted to the position of the Area Sales Manager, until 2014, when joined Qualia Pharma as an Operation & Trade Manager

Antonios Papageorgiou

General Director
Epaminondas (Nodas) Koronis – Pharmazac

Epaminondas (Nodas) Koronis holds a PhD degree from University of Warwick and has completed his post-doc studies at George Washington University. He was a Manager and Pharma consultant at Deloitte and has undertaken executive positions in the pharmaceutical sector and in academia since 2008. In 2014 he joined Pharmazac as a Business Development and now Corporate Development Director.

Epaminondas Koronis

Corporate Development Director

Structure

Administration Team

A team of experts is leading Pharmazac’s strategy and operations. The executive leaders have substantial experience in top management positions in leading organizations.

Governance

The executive team, setting the strategy and the remuneration policies while a strong executive team operates the tactical decision-making. Dedicated committees on Corporate Reputation, Compliance and Human Resources Strategy overview specific areas of importance for the firm and since 2016 a special Advisory Team is engaged in the company’s mega-projects and the Plan of Investments.

Matrix Structure​

Pharmazac is organised as a Matrix where Operational Departments (Development, Manufacturing, Regulatory Affairs, Medical Information, Distribution, Financial Affairs, Exports) meet the firms’ business units that are dedicated on specific domains of the pharmaceutical and healthcare business.

​As part of a dynamic recruiting strategy, Pharmazac welcomes approaches and confidential discussions with established professionals in the field, wishing to enter a fast growing firm and enjoy an excellent business environment and competitive remuneration packages. Direct approaches may be sent straight to the top management of the company